Janux Therapeutics Inc (JANX)
13.96
+2.27%
Janux Therapeutics Inc (JANX) is currently trading at $13.96. This represents a gain of 2.27% from the previous session. With a market capitalization of $0.84B, JANX is a key component of the Health Care sector. Investors looking to trade JANX should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade JANX commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Janux Therapeutics Inc (JANX) shows a bullish trend. Analysts are watching the 13.99 level closely.
Fundamentals
Mkt Cap0.84B
P/E Ratio0.0000
Volume51,767
60-Day Technical Chart
Advanced Charting
Need more indicators for JANX? Use the world's #1 platform.
Open JANX on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $14
| Metric |
JANX +2.27% |
F +0.39% |
SMR +0.37% |
AAL -0.27% |
|---|---|---|---|---|
| Price | $13.96 | $14.26 | $13.46 | $13.11 |
| Mkt Cap | $0.84B | $57.03B | $4.02B | $8.65B |
| - | View → | View → | View → |
Latest Headlines
Autoimmune ‘immune reset’ drug JANX011 begins first human study
Stock Titan • Feb 17, 2026
JANX Enters Global Oncology Collaboration With BMY, Stock Rises
Zacks Investment Research • Jan 23, 2026
$JANX stock is down 46% today. Here's what we see in our data.
Quiver Quantitative • Dec 2, 2025
Janux Therapeutics Craters 53% On Prostate Cancer Update; Is It An 'Overreaction'?
Investor's Business Daily • Dec 2, 2025
Janux Therapeutics (JANX): Valuation Check After Positive JANX007 Phase 1 Data and Sharp Share Price Drop
Yahoo Finance • Dec 4, 2025
● Gemini Agentic AI Analyst Insight for JANX
Market Education
- Understanding Hedge Fund Alpha and Beta: A Guide for New Investors Jun 2, 2024
- Fed talking about Phillips Curve - I want to know what it is and how it impacts the interest rate Jul 18, 2023
- Cannabis Stocks Apr 8, 2024
External Research